8FBK
Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 8.2.1 |
Synchrotron site | ALS |
Beamline | 8.2.1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2021-04-27 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.9791 |
Spacegroup name | P 63 2 2 |
Unit cell lengths | 70.746, 70.746, 200.499 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 61.270 - 3.150 |
R-factor | 0.2709 |
Rwork | 0.267 |
R-free | 0.30880 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.002 |
RMSD bond angle | 0.346 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX (1.19.1_4122) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 61.270 | 3.370 |
High resolution limit [Å] | 3.150 | 3.150 |
Rmerge | 0.266 | 2.286 |
Number of reflections | 5682 | 12073 |
<I/σ(I)> | 6 | 1.1 |
Completeness [%] | 100.0 | 100 |
Redundancy | 11.3 | 12.1 |
CC(1/2) | 0.995 | 0.648 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8 | 293 | 0.2 M magnesium chloride, 0.1 M imidazole, pH 8.0, 35% v/v MPD |